Roman Necina - Feb 1, 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Technology Officer
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Feb 1, 2022
Transactions value $
$103,134
Form type
4
Date filed
2/1/2022, 07:50 PM
Next filing
Apr 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOOK Common Stock Award $38.7K +12.9K +649.8% $3.00 14.9K Feb 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $64.5K +21.5K $3.00 21.5K Feb 1, 2022 Common Stock 21.5K $1.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was awarded 12,892 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
F2 This stock option is fully vested.